Clinical Trial Update: Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects with Diabetic Macular Edema [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and preliminary efficacy of intravitreal injection of a derivative of a nucleoside reverse transcriptase inhibitor in subjects w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Derivative of nucleoside reverse transcriptase inhibitor (intravitreal)

Snippet

Sponsor: Michelle Abou-Jaoude | Conditions: Diabetic Macular Edema | Phase 1 | Status: COMPLETED